BIOMAT Database Logo BIOMAT Database Logo

Partner testing of severe acute respiratory syndrome coronavirus 2-positive women presenting for delivery. 2021

Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Department of Obstetrics & Gynecology, Northwestern University Feinberg School of Medicine, 250 E. Superior St., Room 05-2175, Chicago, IL 60611. Electronic address: Allison.Sakowicz@northwestern.edu.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D018445 Infectious Disease Transmission, Vertical The transmission of infectious disease or pathogens from one generation to another. It includes transmission in utero or intrapartum by exposure to blood and secretions, and postpartum exposure via breastfeeding. Fetomaternal Infection Transmission,Infection Transmission, Fetomaternal,Infection Transmission, Maternal-Fetal,Infection Transmission, Vertical,Maternal-Fetal Infection Transmission,Mother-to-Child Transmission,Pathogen Transmission, Vertical,Vertical Infection Transmission,Vertical Infectious Disease Transmission,Vertical Transmission of Infectious Disease,Infection Transmission, Maternal Fetal,Maternal Fetal Infection Transmission,Mother to Child Transmission,Mother-to-Child Transmissions,Transmission, Fetomaternal Infection,Transmission, Maternal-Fetal Infection,Transmission, Mother-to-Child,Transmission, Vertical Infection,Transmission, Vertical Pathogen,Transmissions, Mother-to-Child,Vertical Pathogen Transmission

Related Publications

Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions.
August 2020, American journal of obstetrics and gynecology,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Repeat positive severe acute respiratory syndrome coronavirus 2 (coronavirus disease 2019) testing ≥90 days apart in pregnant women.
May 2021, American journal of obstetrics & gynecology MFM,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Implementation of universal testing for severe acute respiratory syndrome coronavirus 2 in pregnant women with intended admission for delivery.
November 2020, American journal of obstetrics and gynecology,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Rapid antigen detection testing for universal screening for severe acute respiratory syndrome coronavirus 2 in women admitted for delivery.
May 2021, American journal of obstetrics and gynecology,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Saliva testing for severe acute respiratory syndrome coronavirus 2 in children.
September 2021, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Delivery table shield to assist suspected and confirmed severe acute respiratory syndrome coronavirus 2-positive women in labor.
November 2020, American journal of obstetrics and gynecology,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Severe acute respiratory syndrome coronavirus 2 positive donors: Improving utilization.
February 2023, Transplant infectious disease : an official journal of the Transplantation Society,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Diagnostic performance of antigen testing for severe acute respiratory syndrome coronavirus 2.
June 2021, The Journal of pediatrics,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies.
January 2023, European journal of internal medicine,
Allie Sakowicz, and Jessica Rosati, and Leslie A Caldarelli, and Malika D Shah, and Leena B Mithal, and Emily S Miller
Pool Size Selection When Testing for Severe Acute Respiratory Syndrome Coronavirus 2.
March 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Copied contents to your clipboard!